Harnessing the Power of Co-Inhibition: Immune Checkpoint Inhibitors and Their Role in Modulating Immune Regulatory Pathways in Cancer
The global “Immune Checkpoint Inhibitors Market” is expected to showcase an exponential growth by exhibiting a CAGR of 15% between 2023 and 2035. Roots Analysis, in its latest report, titled, “Immune Checkpoint Inhibitors Market Distribution by Key Immune Checkpoint Targets (B7-H3, CD38, CD40, CD47 and ICOS), Target indications, Mechanism of Action, Therapeutic Modalities...
0 Comments 0 Shares 961 Views 0 Reviews
Sponsored